Nanocomposix, Inc.
- UEI
- EVQMBF7KC8P3
- CAGE
- 3ZAN8
- Primary NAICS
- 541713 Research and Development in Nanotechnology
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Website
- nanocomposix.com
- Founded
- 2004
- Employees
- 51-250
- Estimated annual revenue
- $10M-$50M
- Industry
-
- Materials
- Chemicals
- Commodity Chemicals
- SIC code
- 73 Business Services
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Nanocomposix INC:1166666 [23-000622] | National Insititue of Arthritis and Musculoskeletal and Skin Diseases | $15,025 | |
| Nanocomposix INC:1166666 [23-000212] | National Insititue of Arthritis and Musculoskeletal and Skin Diseases | $15,025 | |
| Lateral flow assay devices | CDC Pittsburgh | $300,000 | |
| Production of aunp for drug delivery to the CNS to monitor efficacy and safety | Food and Drug Administration | $0 | |
| Lateral assay device | CDC Pittsburgh | $249,950 |
About Nanocomposix, Inc.
Nanocomposix, Inc. is a manufacturer of engineered nanoparticles that provides precisely engineered and highly characterized nanoparticles to help customers bring nanotechnology enabled products to market. Through past prime federal contract awards, Nanocomposix has provided lateral flow assay devices, gold nanoparticles, and research and development services for biomedical technologies such as HIV vaccines, tuberculosis diagnostics, and cytomegalovirus assays. Major funding agencies have included the Department of Health and Human Services (National Institutes of Health, Food and Drug Administration, Centers for Disease Control and Prevention) and Department of Defense (Army). Several contracts were set aside for small businesses. As a subcontractor, Nanocomposix has produced pilot lots for clinical trials. Through a prime federal grant award from the National Institutes of Health, Nanocomposix developed the first commercial rapid diagnostic test to detect Paragonimus infections.
Quick answers
What is Nanocomposix, Inc.'s UEI?
Nanocomposix, Inc.'s Unique Entity ID (UEI) in SAM.gov is EVQMBF7KC8P3.
What is Nanocomposix, Inc.'s CAGE code?
Nanocomposix, Inc.'s CAGE code is 3ZAN8.
What is Nanocomposix, Inc.'s primary NAICS code?
Nanocomposix, Inc.'s primary NAICS code is 541713 (Research and Development in Nanotechnology).
Is Nanocomposix, Inc. registered in SAM.gov?
Nanocomposix, Inc.'s SAM.gov registration expired on April 28, 2023.
What is Nanocomposix, Inc.'s most recent federal award?
Nanocomposix, Inc.'s most recent federal contract award is Nanocomposix INC:1166666 [23-000622] (75N92B23P00011), from National Insititue of Arthritis and Musculoskeletal and Skin Diseases, on December 5, 2022.
On GovTribe
See Nanocomposix, Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors